Category
»
Primary study
Registry of Trials»Brazilian Registry of Clinical Trials
Year
»
2018
Links
»
INTERVENTION: Control Group (CONT): participants will be submitted to treatment by means of a myoclonus occlusal plaque. Patients will be instructed to use the plaque for 8 hours daily at night. Single Point Atrial Acupuncture Treatment Group (AAU): Patients will receive AA treatment using disposable semipermanent needles at point related to the jaws in the ear on the dominant side of the body. Group AA Sham (SHU): Participants will be treated by AA in a manner identical to the Treatment Group, except for the location of the spot. In this group will be used acuponto 180.C3, not related to the jaws or structures involved with Temporomandibular Dysfunction. Group Treatment Ear acupuncture by combination of stitches (AAC): patients will receive treatment using AA using disposable semipermanent needles (Moxon, Germany) at: Temporomandibular joint (TMJ), Shenmen and center of the ear concha in the ear side of dominance of the body. Group AA Sham by combination of points (SHC): participants will receive AA treatment in an identical manner to the Treatment Group, except for the location of the acupoints in the Hélix, not related to the jaws or structures involved with Temporomandibular Dysfunction. Laser Auriculoterapia Group (ALA): Patients who will receive auriculotherapy with low power laser and contact application method. The application will be held in the following points Shenmen, TMJ, heart, in the ear of the dominance side of the body. Eight laser auriculotherapy sessions will be held, which will be held once a week. Associated Therapies Group (ASS): patients will receive the treatment with myorelaxant plaque (CONT) and auriculoterapia with laser (ALA). Auriculotherapy needles will be maintained for 48 hours in all patients, and applications will be performed once a week, for a total treatment period of 8 weeks. Sobre o Google TradutorComunidadeCelular. All experimental groups will have 20 volunteers each. E02.190.044.133 Procedure/surgery CONDITION: A02.835.583.861 Disorders of the temporomandibular articulation; Dysfunction Syndrome Temporomandibular Joint ; A02.835.583.861 ; K07.6 SECONDARY OUTCOME: Improvement of the non‐specific physical symptoms scores evaluated for the treatment groups compared to the control group verified by visual analog scale scores submitted to non‐parametric statistical analysis, p <0.05, in the comparison between the groups INCLUSION CRITERIA: Adult volunteers aged 18 years or over; score equal to or greater than 3 in the Triage Questionnaire of the American Academy of Orofacial Pain; with the presence of myofascial pain according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC / TMD). PRIMARY OUTCOME: Decreased pain scores verified by means of the visual analogue scale method, in the assessment of painful sites to muscle and joint palpation submitted to non‐parametric statistical analysis, p <0.05, in the comparison between groups; Improvement of the psycho‐emotional aspects, reduction of depression based on the Depression Scale (DEP) of the Symptoms‐Checklist‐90 (SCL‐90) submitted to non‐parametric statistical analysis, p <0.05, in the comparison between the groups; Reduction of disability related to chronic pain verified by the Graded Chronic Pain Scale (GCPS) scores submitted to non‐parametric statistical analysis, p <0.05, in the comparison between groups; Decreased somatization scores verified by non‐specific physical symptoms, including and excluding pain, based on the somaticisation domain of Symptoms‐Checklist‐90 (SCL‐90) submitted to non‐parametric statistical analysis , p <0.05, in the comparison between groups
Epistemonikos ID: f0488dc8cc5faad655a65947b78631334d8b2ea0
First added on: Aug 24, 2024